Raven Jaeger

46 year

Health Technology

Consumer Services

Profile

Raven D.
Jaeger is currently the Chief Regulatory Officer at CalciMedica, Inc. Prior to this, she held the position of Director-Regulatory Affairs at Leadiant Biosciences, Inc. from 2011 to 2018.
In 2022, she served as the Chief Regulatory Officer at Diffusion Pharmaceuticals, Inc. Ms. Jaeger also worked as the Senior Vice President-Regulatory Affairs at BridgeBio Pharma, Inc. Ms. Jaeger completed her undergraduate degree at The Johns Hopkins University and her graduate degree at the University of Maryland.

Raven Jaeger active positions

Companies	Position	Start
CALCIMEDICA, INC.	General Counsel	23/05/2023

All active positions of Raven Jaeger

Former positions of Raven Jaeger

Companies	Position	End
DIFFUSION PHARMA	General Counsel	01/03/2023
Leadiant Biosciences, Inc. Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD.	Corporate Officer/Principal	01/04/2018
BRIDGEBIO PHARMA, INC.	General Counsel	-

See the detail of Raven Jaeger's experience

Training of Raven Jaeger

The Johns Hopkins University	Undergraduate Degree
University of Maryland	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Raven Jaeger's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
BRIDGEBIO PHARMA, INC.	Health Technology
CALCIMEDICA, INC.	Health Technology

Private companies	2
Diffusion Pharmaceuticals, Inc. Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.	Health Technology
Leadiant Biosciences, Inc. Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD.	Health Technology